| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 8. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | macrogol '3350'/sodium chloride/sodium hydrogen carbonate/potassium chloride (CosmoCol Half®) |
| Formulation | 6.9 g powder for oral solution |
| Reference number | 2575 |
| Indication | Treatment of chronic constipation and faecal impaction in adolescents, adults and the elderly. For resolving faecal impaction in adults, adolescents and the elderly. Faecal impaction is defined as refractory constipation with faecal loading in the rectum and/or colon confirmed by physical or radiological examination of the abdomen and rectum |
| Company | Stirling Anglian Pharmaceuticals Ltd |
| BNF chapter | Gastro-intestinal system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 24/10/2014 |